6Furman PA, Mcguirt PV, Keller PM, et al. Inhibition of ACV of cell growth and DNA synthesis of cells biochcmically transformed with herpes virus genetic information[J]. Virol, 1980, 102: 420-430.
7Freeman SM, Abbound CN, Whartenby KA, et al. The "bystander effectn : Tumor regression when a fraction of the tumor mass is genetically modified[J]. Cancer Res, 1993, 53 : 5274-5283.
8Moolten FL. Tumor Chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy[J]. Cancer Res, 1986, 46: 5276-5281.
9Moolten FL, Wells J-M, Heyman RA, et al. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene[J]. Hum C, ene Ther, 1990, 1 : 125-134.
10Moolten FL, Wells JIM. Curability of tumors bearing herpes thymidine kitmse genes transferred by retroviml vectors[J]. J Nail Cancer Inst, 1990, 82(4) : 297-300.
1Casado E, Nettelbeck DM, Gomez-Navarro J, et al. Transcriptional targeting for ovarian cancer gene therapy[J]. Gynecol Oncol, 2001, 82(2): 229-237.
2Boussif O, Lezoualc′h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine[J]. Proc Natl Acad Sci U S A, 1995, 92(16): 7297-7301.
3Choosakoonkriang S, Lobo BA, Koe GS, et al. Biophysical characterization of PEI/DNA complexes[J]. J Pharm Sci, 2003, 92(8): 1710-1722.
4Forrest ML, Koerber JT, Pack DW. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery[J].Bioconjug Chem, 2003,14(5): 934-940.
5Alvarez RD,Gomez-Navarro J,Wang M, et al. Adenoviral-mediated suicide gene therapy for ovarian cancer[J]. Mol Ther, 2000,2(5): 524-530.
6Kircheis R,Wightman L,Wagner E. Design and gene delivery activity of modified polyethylenimines[J]. Adv Drug Deliv Rev, 2001, 53(3): 341-358.
7Lee SJ, Kim HS, Yu R, et al. Novel prostate-specific promoter derived from PSA and PSMA enhancers[J]. Mol Ther, 2002, 6(3): 415-421.
8Selvakumaran M, Bao R, Crijns AP, et al. Ovarian epithelial cell lineage-specific gene expression using the promoter of a retrovirus-like element[J]. Cancer Res, 2001, 61(4): 1291-1295.
